BHCM
Brevan Howard Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-4,595
| Closed | -$216K | – | 1073 |
|
2024
Q3 | $216K | Buy |
+4,595
| New | +$216K | ﹤0.01% | 916 |
|
2024
Q1 | – | Sell |
-5,812
| Closed | -$364K | – | 1011 |
|
2023
Q4 | $364K | Buy |
+5,812
| New | +$364K | ﹤0.01% | 583 |
|
2021
Q2 | – | Sell |
-14,911
| Closed | -$1.82M | – | 32 |
|
2021
Q1 | $1.82M | Sell |
14,911
-8,289
| -36% | -$1.01M | 0.27% | 24 |
|
2020
Q4 | $3.55M | Buy |
+23,200
| New | +$3.55M | 0.71% | 17 |
|